The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open‑label, randomised controlled trial
type: Dataset
applicable legislation: oj
max typical age: 93
min typical age: 23
number of unique individuals: 54
population coverage: collection type: Hospital,Longitudinal,Sample collection,Other | disease: Pneumonia due to staphylococcus aureus | data categories: Physiological/Biochemical measurements | materials: Not available | omics: Not available | imaging: N | sex: Female,Male
access rights: RESTRICTED
creator: Dutch Cardiovascular Alliance (DCVA)
description: We investigated whether hyperaggregation occurs during infection, and whether aspirin inhibits this. Patients hospitalised due to acute infection were randomised to receive 10 days of aspirin treatment or no intervention. Our outcome measures were PFA-Closure Time, serum thromboxane and plasma thromboxane.
is referenced by: s10238-023-01101-5
is referenced by: https://pubmed.ncbi.nlm.nih.gov/37294478/
issued: 2018-01-11T00:00:00+00:00
language: en
modified: 2026-08-08T02:28:20.364022
provenance: ProvenanceStatement
publisher: Dutch Cardiovascular Alliance (DCVA)
spatial: NLD
temporal: PeriodOfTime
  end date: 2020-12-10T00:00:00+00:00
  start date: 2018-01-11T00:00:00+00:00
contact point: Kind
  fn: DCVA
  has URL: ']
keyword: ASPIRIN
keyword: Female
keyword: Hospital
keyword: Longitudinal
keyword: Male
keyword: Not available
keyword: Other
keyword: Physiological Biochemical measurements
keyword: Pneumonia due to staphylococcus aureus
keyword: Sample collection
qualified attribution: Attribution
  agent: Dutch Cardiovascular Alliance (DCVA)
theme: HEAL